Humana (HUM) is an average quality business scoring 55/100. While the company generates positive returns, it lacks the exceptional attributes that characterize durable competitive advantages. Investors should demand a meaningful discount to fair value before investing.
Humana shows limited evidence of a durable competitive moat. Margins and returns on capital are below levels that would indicate meaningful competitive advantages. The business may struggle to maintain its current profitability as competitive dynamics evolve.
Humana has limited pricing power. The company operates with margins that are average for its industry, and revenue growth has come with some margin pressure. This suggests the business competes partially on price rather than on differentiated value.
Humana is a highly predictable business with remarkably consistent financial performance. Revenue growth has been steady with low volatility, and the company has delivered positive free cash flow in 6 of the last 6 years. This consistency makes future earnings relatively easy to forecast with confidence.
Humana has an exceptionally strong balance sheet with low leverage. The company could comfortably weather a severe economic downturn. This financial fortress provides strategic flexibility and reduces risk for long-term shareholders.
Humana shows solid capital allocation. Returns on capital exceed the cost of capital, and management balances reinvestment with shareholder returns reasonably well. There is room for improvement, but overall capital deployment creates value.
Humana's management shows mixed results. Operational efficiency could be improved, and capital deployment decisions have been inconsistent. The team needs to demonstrate clearer focus on shareholder value creation.

Predicted probability of operating margin improvement over the next 12 months
Humana est-elle un bon investissement à $352 ?
L'analyse suivante est fournie à des fins d'information et d'éducation uniquement. Elle ne constitue pas un conseil financier, un conseil en investissement ou une recommandation d'achat ou de vente de titres. Les opinions exprimées sont basées sur des informations publiques et des données historiques. Beanvest et ses contributeurs peuvent détenir des positions dans les titres mentionnés. Les investisseurs doivent effectuer leur propre diligence raisonnable ou consulter un conseiller financier agréé avant de prendre toute décision d'investissement.